Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India
about
Health economic evaluations of visceral leishmaniasis treatments: a systematic reviewMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisCost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinentLive vaccination tactics: possible approaches for controlling visceral leishmaniasisWho is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South AsiaOptions for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.Structures, targets and recent approaches in anti-leishmanial drug discovery and development.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.The economic value of a visceral leishmaniasis vaccine in Bihar state, India.Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™).Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-Glutamic Acid) complex.Assessing the quality of pharmacoeconomic studies in India: a systematic review.A Systematic Review of the State of Economic Evaluation for Health Care in India.Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar).Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil.15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.Leishmaniasis in humans: drug or vaccine therapy?Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil.Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis.Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseasesVisceral Leishmaniasis - Current Treatments and Needs
P2860
Q28084540-7785C933-F312-4639-A9D7-26FBD9808233Q28271849-17BF7437-064F-4ABE-88B4-84AE17D445C2Q28475431-37F3089F-8532-46D3-9259-F580E5AAE3EDQ28542081-6D096A4B-5449-47AA-B91C-07AD2128E76AQ28741732-0A983CDF-EA4C-44FB-857A-6222214E3BD8Q33828879-949A2BAF-558A-43D9-AC91-35B81D6F143CQ35012968-C442E41B-3C22-405A-8945-0D2C16585094Q35168703-563A4194-0A8F-4D3D-A03B-DCBBE6FE410CQ35771782-2DDAA758-B2F5-4480-B1C5-73CBB4003371Q36455848-A40C57F4-9161-4D66-8407-7546EC773077Q37263800-240605D4-E993-45D7-8470-C287F17C2E28Q38020528-5340E450-3947-49AC-9C86-A0D38ECB5CBEQ38602629-EC02E217-7F32-4EF4-8427-9CD451B5D29FQ39599468-AFB7D336-C8E2-4160-8ECE-171CC206DD56Q40342021-66560486-DD82-4FA7-92AD-C65CB3D96808Q40810593-E9808A93-62C4-44AC-AA68-1423DC2932CCQ41703512-2805D431-BC8E-4A9C-926F-5A0008E1C48AQ43167558-7DEA592B-D8A2-4021-AC51-602B4CE7B39CQ47556262-2656D48E-9F42-46D2-87D6-114167022ED0Q50150753-7EDE4AC8-0616-4629-A9E4-A57A334E6088Q50677795-D6831AC5-974C-4966-9A39-8125C1326E58Q57347954-19A56C22-7623-4B1C-91E7-72B5EE7DF801Q59003562-7499649D-2FDC-442D-AD0B-9182CD8B53D7
P2860
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@ast
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@en
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@nl
type
label
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@ast
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@en
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@nl
prefLabel
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@ast
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@en
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@nl
P1476
Cost-effectiveness projections ...... leishmaniasis in Bihar, India
@en
P2093
Ramanan Laxminarayan
Sarah Darley
P304
P356
10.1111/J.1365-3156.2009.02306.X
P407
P577
2009-08-01T00:00:00Z